Literature DB >> 3902477

Gastro-oesophageal reflux--pathogenesis and clinical implications.

T R Weihrauch.   

Abstract

Gastro-oesophageal reflux is a common phenomenon in young infants. Normally it will disappear during the first months of life. The most important antireflux mechanism is the lower oesophageal sphincter (LOS). Another main factor to prevent reflux is an adequate oesophageal clearance. The significance of the upper oesophageal sphincter (UOS) and gastric emptying as antireflux barriers has yet to be clarified. Primary or secondary impairment of physiological antireflux factors may lead to a considerable number of clinical complications.

Entities:  

Mesh:

Year:  1985        PMID: 3902477     DOI: 10.1007/bf00451943

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  40 in total

1.  Maturation of the lower esophagus.

Authors:  J Boix-Ochoa; J Canals
Journal:  J Pediatr Surg       Date:  1976-10       Impact factor: 2.545

2.  Lower esophageal sphincter function in children with and without gastroesophageal reflux.

Authors:  S P Moroz; J Espinoza; W A Cumming; N E Diamant
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

3.  Cholinergic therapy of chronic heartburn. A controlled trial.

Authors:  R L Farrell; G T Roling; D O Castell
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

4.  Postoperative reflux alkali gastritis and esophagitis.

Authors:  S Mackman; K E Lemmer; J F Morrissey
Journal:  Am J Surg       Date:  1971-06       Impact factor: 2.565

5.  Clinical significance of gastro-oesophageal reflux.

Authors:  S J Carré
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

6.  Upper esophageal sphincter: does it care about reflux?

Authors:  D H Winship
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

7.  Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide.

Authors:  J Behar; G Ramsby
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Mechanisms of gastroesophageal reflux in children.

Authors:  S L Werlin; W J Dodds; W J Hogan; R C Arndorfer
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

9.  Muscular equivalent of the lower esophageal sphincter.

Authors:  D Liebermann-Meffert; M Allgöwer; P Schmid; A L Blum
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Pathogenesis of esophagitis in patients with gastroesophageal reflux.

Authors:  A G Little; T R DeMeester; P T Kirchner; G C O'Sullivan; D B Skinner
Journal:  Surgery       Date:  1980-07       Impact factor: 3.982

View more
  5 in total

1.  Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.

Authors:  Y Preechagoon; B Charles; V Piotrovskij; T Donovan; A Van Peer
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.

Authors:  J P Buts; C Barudi; J B Otte
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

3.  Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.

Authors:  S Cucchiara; A Staiano; A Boccieri; M De Stefano; C Capozzi; G Manzi; F Camerlingo; F M Paone
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

4.  Cisapride for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; C Capozzi; C Di Lorenzo; A Boccieri; S Auricchio
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

5.  Gastro-oesophageal reflux in infants. Evaluation of treatment by pH monitoring.

Authors:  Y Vandenplas; L Sacré-Smits
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.